Sector | Healthcare | Compare with Sector peers |
Industry | Pharmaceuticals & Drugs | Compare with Industry peers |
Website | http://www.jbpharma.com | |
Market Cap | 25,598.61 Cr. | |
Enterprise Value(EV) | 25,932.51 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 33.13 | Trailing Twelve Months Ending 2023-12 |
Price-Earning Ratio (PE) | 49.79 | Trailing Twelve Months Ending 2023-12 |
Industry PE | 41.54 | Trailing Twelve Months Ending 2023-12 |
Book Value / Share | 183.66 | Trailing Twelve Months Ending 2023-12 |
Price to Book Value | 8.98 | Calculated using Price: 1,649.45 |
Dividend Yield | 0.54 | Period Ending 2023-03 |
No. of Shares Subscribed | 15.52 Cr. | 155,194,800 Shares |
FaceValue | 1 | |
About JB Chemicals & Pharmaceuticals Ltd. | ||
J. B. Chemicals & Pharmaceuticals is engaged in the business of manufacturing and marketing of diverse range of pharmaceutical formulations, herbal remedies and APIs. JBCPL is widely committed to manufacturing a range of innovative specialty products that include various pharmaceutical dosage forms like tablets, injectable (vials, ampoules, form fill seal), creams & ointments, lozenges, herbal liquids and capsules. In India and International markets, JBCPL is also known as Unique Pharmaceutical Laboratories and is a division of JBCPL. |
1 Day |
|
+0.97% |
1 Week |
|
+4.72% |
1 Month |
|
+1.08% |
3 Month |
|
+2.37% |
6 Month |
|
+17.69% |
1 Year |
|
+70.49% |
2 Year |
|
+112.19% |
5 Year |
|
+839.94% |
10 Year |
|
+2572.03% |
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 9.86 | 14.93 | 14.48 | 9.89 | 13.28 | 18.69 | 27.64 | 19.89 | 18.51 | |
Return on Capital Employed (%) | 13.49 | 17.83 | 16.87 | 13.7 | 19.59 | 23.71 | 36.53 | 25.48 | 22.79 | |
Return on Assets (%) | 7.08 | 9.29 | 8.99 | 6.43 | 8.52 | 12.53 | 19.55 | 13.69 | 11.44 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 995 | 1,184 | 1,364 | 1,442 | 1,480 | 1,435 | 1,810 | 2,134 | 2,480 | 2,717 | |
Non Curr. Liab. | 33 | 31 | 27 | 46 | 65 | 63 | 72 | 475 | 992 | 434 | |
Curr. Liab. | 460 | 797 | 693 | 737 | 782 | 516 | 687 | 455 | 626 | 643 | |
Minority Int. | 2 | 2 | 3 | 3 | 3 | 4 | 4 | ||||
Equity & Liab. | 1,487 | 2,014 | 2,086 | 2,226 | 2,329 | 2,017 | 2,572 | 3,069 | 4,098 | 3,794 | |
Non Curr. Assets | 586 | 832 | 879 | 718 | 741 | 741 | 679 | 1,745 | 2,499 | 2,036 | |
Curr. Assets | 901 | 1,182 | 1,207 | 1,509 | 1,589 | 1,276 | 1,894 | 1,325 | 1,599 | 1,758 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 1,487 | 2,014 | 2,086 | 2,226 | 2,329 | 2,017 | 2,572 | 3,069 | 4,098 | 3,794 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
Net Sales | 1,144 | 1,232 | 1,368 | 1,414 | 1,643 | 1,775 | 2,043 | 2,424 | 3,149 | 3,385 | |
Other Income | 11 | 57 | 54 | 55 | 41 | 51 | 117 | 40 | 10 | 25 | |
Total Income | 1,155 | 1,288 | 1,422 | 1,469 | 1,685 | 1,826 | 2,159 | 2,464 | 3,159 | 3,410 | |
Total Expenditure | -964 | -1,026 | -1,140 | -1,215 | -1,337 | -1,397 | -1,486 | -1,882 | -2,454 | -2,522 | |
PBIDT | 191 | 263 | 283 | 254 | 347 | 428 | 673 | 583 | 706 | 888 | |
Interest | -7 | -11 | -5 | -3 | -5 | -3 | -7 | -5 | -36 | -49 | |
Depreciation | -39 | -41 | -47 | -57 | -56 | -66 | -69 | -73 | -114 | -129 | |
Taxation | -45 | -50 | -46 | -55 | -93 | -77 | -148 | -119 | -145 | -195 | |
Exceptional Items | -10 | ||||||||||
PAT | 100 | 163 | 184 | 139 | 194 | 272 | 449 | 386 | 410 | 514 | |
Minority Interest | 0 | 0 | 0 | -1 | 0 | -1 | -1 | 0 | |||
Share Associate | |||||||||||
Other Related Items | |||||||||||
Consolidated Net Profit | 100 | 163 | 184 | 138 | 193 | 272 | 448 | 385 | 410 | 514 | |
Adjusted EPS | 6 | 10 | 11 | 8 | 12 | 18 | 29 | 25 | 26 | 33 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | -14 | 127 | 140 | 201 | 123 | 194 | 276 | 315 | 170 | 626 | |
Cash Fr. Inv. | -143 | -112 | -28 | -45 | -21 | -28 | 24 | -231 | 2 | -962 | |
Cash Fr. Finan. | 12 | -1 | -100 | -184 | -60 | -156 | -306 | -87 | -138 | 357 | |
Net Change | -144 | 13 | 13 | -28 | 43 | 11 | -6 | -3 | 34 | 20 | |
Cash & Cash Eqvt | 12 | 25 | 9 | -21 | 21 | 32 | 26 | 22 | 57 | 77 |
Wed, 27 Mar 2024
Closure of Trading Window Intimation of Trading Window Closure period |
Fri, 22 Mar 2024
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 Disclosure under Regulation 30 - Receipt of Order |
Sat, 09 Mar 2024
Announcement under Regulation 30 (LODR)-Newspaper Publication Newspaper advertisement for Postal Ballot |
Thu, 28 Mar 2024 |
Close Crossing Last Week High |
Opening at Low |
Close Within 52 Week High Zone |
Close Above Last Week High |
Making Higher Highs for 2 Days |